Adenovirus-vectored drug-vaccine duo as a potential driver for conferring mass protection against infectious diseases (Q37951524)

25 August 2017

title

Adenovirus-vectored drug-vaccine duo as a potential driver for conferring mass protection against infectious diseases (English)

1 reference

25 August 2017

0 references

1 reference

Jianfeng Zhang

1

1 reference

25 August 2017

E Bart Tarbet

series ordinal

2

1 reference

25 August 2017

Haroldo Toro

series ordinal

3

1 reference

25 August 2017

De-chu C Tang

series ordinal

4

1 reference

25 August 2017

publication date

1 November 2011

1 reference

Expert Review of Vaccines

25 August 2017

published in

1 reference

25 August 2017

volume

10

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

1539-1552

1 reference

Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Inflammatory exposure and historical changes in human life-spans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Inflammatory mechanisms in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

In vitro induction of mucosa-type dendritic cells by all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Lymph node stromal cells support dendritic cell-induced gut-homing of T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Topical application of Escherichia coli-vectored vaccine as a simple method for eliciting protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Dissolving polymer microneedle patches for influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

In vivo function of Langerhans cells and dermal dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Enemy at the gates: dendritic cells and immunity to mucosal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Generation of mucosal dendritic cells from bone marrow reveals a critical role of retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Delivery of human immunodeficiency virus vaccine vectors to the intestine induces enhanced mucosal cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Comparison of adenoviruses from species B, C, E, and F after intravenous delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Creation of a panel of vectors based on ape adenovirus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

A porcine adenovirus with low human seroprevalence is a promising alternative vaccine vector to human adenovirus 5 in an H5N1 virus disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Cross-species transmission of a novel adenovirus associated with a fulminant pneumonia outbreak in a new world monkey colony

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Novel Adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Genetic immunization in the lung induces potent local and systemic immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Complex effect of adenovirus early region proteins on innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

The biology of airway dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Development and functional specialization of CD103+ dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Adenovirus-transduced lung as a portal for delivering alpha-galactosidase A into systemic circulation for Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Influenza-associated central nervous system dysfunction: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

TLR3 deficiency in patients with herpes simplex encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Electroporation for DNA immunization: clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

DNA vaccines: ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Development of stable liquid formulations for adenovirus-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Development of formulations that enhance physical stability of viral vectors for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Adenovirus-vectored drug-vaccine duo as a rapid-response tool for conferring seamless protection against influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Induction of type I interferon by adenovirus-encoded small RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Pulmonary immunity to viral infection: adenovirus infection of lung dendritic cells renders T cells nonresponsive to interleukin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Augmented lung inflammation protects against influenza A pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Influenza virus resistance to antiviral agents: a plea for rational use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Attenuation of inducible respiratory immune responses by oseltamivir treatment in mice infected with influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Protection of chickens against avian influenza with nonreplicating adenovirus-vectored vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Induction of mucosal immunity in the avian Harderian gland with a replication-deficient Ad5 vector expressing avian influenza H5 hemagglutinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Avian influenza vaccination in chickens and pigs with replication-competent adenovirus-free human recombinant adenovirus 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Adenovirus-based prime-boost immunization for rapid vaccination against anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

An adenoviral vector-based mucosal vaccine is effective in protection against botulism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Adenovirus-based genetic vaccines for biodefense

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

Vaccination onto bare skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.141

21 January 2018

Identifiers

DOI

10.1586/ERV.11.141

1 reference

25 August 2017

1 reference